Cite
HARVARD Citation
Thibault, N. et al. (2018). Idarucizumab for Reversing Dabigatran-Induced Anticoagulation. American journal of therapeutics. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Thibault, N. et al. (2018). Idarucizumab for Reversing Dabigatran-Induced Anticoagulation. American journal of therapeutics. p. . [Online].